Traditional drug delivery methods often lack precision, leading to systemic side effects and reduced therapeutic outcomes. Nanocarriers offer a solution by enhancing the bioavailability of drugs, protecting them from degradation, and ensuring targeted delivery. This precision minimizes adverse effects and increases the effectiveness of treatments, particularly in oncology, where targeted therapy is crucial.
